Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
No	O
Known	O
Allergies	O
/	O
Adverse	O
Drug	O
Reactions	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Right	O
arm	B-Proximal_humeral_fracture
fracture	B-Proximal_humeral_fracture
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
Right	O
humerus	B-Proximal_humeral_fracture
ORIF	O
History	O
of	O
Present	O
Illness:	O
___	O
PMH	O
of	O
castration-resistant	O
metastatic	O
prostate	O
cancer	O
(previously	O
on	O
docetaxel,	O
now	O
s/p	O
cycle	O
4	O
radium),	O
DVT	O
(on	O
Eliquis),	O
T2DM,	O
CAD,	O
presented	O
to	O
ED	O
with	O
right	O
arm	O
pain	O
found	O
to	O
have	O
pathologic	O
fracture	B-Proximal_humeral_fracture
of	O
right	O
humerus,	B-Proximal_humeral_fracture
admitted	O
for	O
pain	O
control	O
and	O
further	O
management	O
Patient	O
reported	O
that	O
he	O
has	O
been	O
at	O
rehab	O
for	O
the	O
past	O
2	O
weeks	O
working	O
on	O
mobility	B-Mobile_with_aid
with	B-Mobile_with_aid
a	B-Mobile_with_aid
walker,	B-Mobile_with_aid
due	O
to	O
chronic	O
deficits	O
in	O
right	O
lower	O
leg.	O
He	O
noted	O
that	O
he	O
did	O
not	O
make	O
much	O
progress	O
overall.	O
On	O
day	O
of	O
admission,	O
he	O
tried	O
to	O
support	O
himself	O
with	O
his	O
arms	O
to	O
get	O
up	O
using	O
his	O
walker,	B-Mobile_with_aid
heard	O
a	O
loud	O
pop,	O
and	O
had	O
immediate	O
pain	O
in	O
his	O
right	O
upper	O
arm.	O
Called	O
___	O
and	O
was	O
brought	O
to	O
the	O
ED.	O
In	O
the	O
ED,	O
initial	O
vitals:	O
98.1	O
92	O
104/50	O
18	O
100%	O
RA.	O
UA	O
negative	O
for	O
infection.	O
Right	O
Shoulder	O
Xray:	O
1.	O
Acute	O
fracture	B-Proximal_humeral_fracture
extending	O
obliquely	O
through	O
the	O
right	O
proximal	B-Proximal_humeral_fracture
humerus	B-Proximal_humeral_fracture
with	O
minimal	O
displacement.	O
2.	O
Thickening	O
of	O
the	O
right	O
humeral	B-Proximal_humeral_fracture
cortex	O
and	O
heterogeneity	O
of	O
the	O
medullary	O
cavity	O
is	O
concerning	O
for	O
underlying	O
infiltrative	O
process,	O
especially	O
given	O
patient	O
history.	O
MRI	O
could	O
be	O
considered	O
for	O
further	O
evaluation	O
of	O
underlying	O
bone	O
marrow	O
to	O
confirm	O
that	O
this	O
is	O
a	O
pathologic	O
fracture.	B-Proximal_humeral_fracture
3.	O
In	O
addition,	O
areas	O
of	O
relative	O
increased	O
sclerosis	O
in	O
regions	O
of	O
the	O
right	O
lateral	O
ribs	O
and	O
inferior	O
tip	O
of	O
the	O
right	O
scapula	O
concerning	O
for	O
metastatic	O
disease.	O
Right	O
Humerus	B-Proximal_humeral_fracture
Xray:	O
Again	O
seen	O
is	O
a	O
mottled	O
appearance	O
of	O
the	O
right	O
humerus	O
with	O
an	O
oblique	O
fracture	B-Proximal_humeral_fracture
through	O
the	O
proximal	O
to	O
mid	O
right	O
humeral	O
diaphysis.	O
No	O
significant	O
displacement.	O
Distally,	O
no	O
additional	O
fractures	O
identified.	O
Ortho	O
was	O
consulted,	O
rec'd	O
sling	O
for	O
time	O
being	O
while	O
awaiting	O
final	O
recs.	O
Patient	O
was	O
given	O
NS	O
and	O
oxycontin/oxycodone	O
prior	O
to	O
admission.	O
Past	O
Medical	O
History:	O
-Metastatic	O
Prostate	O
Cancer	O
c/b	O
pathologic	O
fracture	O
of	O
right	O
femur	O
s/p	O
surgical	O
correction	O
___	O
yr	O
prior	O
-CAD	O
s/p	O
MI	O
-Type	O
II	O
Diabetes	O
-Hypertension	O
-DVT	O
Social	O
History:	O
___	O
Family	O
History:	O
Brother	O
with	O
diabetes.	O
Physical	O
Exam:	O
Admission:	O
GENERAL:	O
laying	O
in	O
bed,	O
appears	O
calm,	O
comfortable	O
at	O
rest,	O
only	O
in	O
pain	O
with	O
movement	O
EYES:	O
PERRLA,	O
anicteric	O
HEENT:	O
OP	O
clear,	O
MMM	O
NECK:	O
supple,	O
normal	O
ROM	O
LUNGS:	O
CTA	O
anteriorly,	O
no	O
wheezes/rales/rhonchi,	O
normal	O
RR	O
CV:	O
RRR	O
no	O
m/r/g,	O
normal	O
distal	O
perfusion	O
ABD:	O
soft,	O
NT,	O
nD,	O
normoactive	O
BS	O
GENITOURINARY:	O
no	O
foley	O
or	O
suprapubic	O
tenderness	O
EXT:	O
warm,	O
has	O
asymmetric	O
swelling/edema	O
of	O
RLE	O
which	O
he	O
noted	O
is	O
stable	O
since	O
last	O
admission	O
when	O
he	O
was	O
diagnosed	O
with	O
DVT.	O
___	O
has	O
chronic	O
sensory	O
issues	O
s/p	O
chemo	O
extravasation	O
in	O
past,	O
but	O
sensation	O
is	O
at	O
his	O
baseline,	O
has	O
normal	O
pulses	O
and	O
distal	O
perfusion	O
intact.	O
Has	O
weak	O
grip	O
strength	O
of	O
RUE	O
which	O
he	O
noted	O
is	O
chronic	O
___	O
chemo	O
extravasation	O
incident.	O
Has	O
tenderness	O
in	O
right	O
humerus	O
with	O
palpation.	O
right	O
arm	O
in	O
sling	O
SKIN:	O
warm,	O
dry,	O
has	O
hyperpigmentation	O
of	O
RLE	O
NEURO:	O
AOx3,	B-Delirium
fluent	O
speech	O
ACCESS:	O
PORT	O
dressing	O
c/d/I	O
Discharge:	O
General:	O
NAD,	O
calm,	O
laying	O
in	O
bed,	O
pleasant	O
EYES:	O
Anicteric	O
HENT:	O
MMM	O
CV:	O
RRR	O
no	O
m/r/g,	O
normal	O
distal	O
perfusion	O
PULM:	O
CTAB	O
anteriorly	O
though	O
as	O
unable	O
to	O
sit	O
forward.	O
Speaking	O
in	O
full	O
sentences	O
ABD:	O
BS+,	O
Soft,	O
NT,	O
ND,	O
normoactive	O
BS	O
EXT:	O
warm,	O
has	O
asymmetric	O
swelling/edema	O
of	O
RLE	O
which	O
he	O
noted	O
is	O
stable	O
since	O
last	O
admission	O
when	O
he	O
was	O
diagnosed	O
with	O
DVT.	O
___	O
has	O
chronic	O
sensory	O
issues	O
s/p	O
chemo	O
extravasation	O
in	O
past,	O
but	O
sensation	O
is	O
at	O
his	O
baseline,	O
radial	O
pulses	O
b/l	O
strong	O
and	O
synchronous,	O
distal	O
perfusion	O
intact.	O
slight	O
edema	O
of	O
right	O
hand.	O
Has	O
weak	O
grip	O
strength	O
of	O
RUE	O
which	O
he	O
noted	O
is	O
chronic	O
___	O
chemo	O
extravasation	O
incident	O
however	O
post-op	O
slightly	O
weaker.	O
Can	O
lift	O
his	O
legs	O
b/l	O
a	O
few	O
inches	O
off	O
the	O
bed,	O
R	O
weaker	O
than	O
L	O
SKIN:	O
No	O
rashes	O
on	O
extremities,	O
warm/dry	O
NEURO:	O
Speech	O
fluent,	O
AOx3	B-Delirium
PSYCH:	O
pleasant,	O
calm	O
ACCESS:	O
port	O
dressing	O
c/d/I	O
Pertinent	O
Results:	O
Discharge:	O
___	O
04:49AM	O
BLOOD	O
WBC-2.7*	O
RBC-2.78*	O
Hgb-7.5*	O
Hct-23.9*	O
MCV-86	O
MCH-27.0	O
MCHC-31.4*	O
RDW-17.5*	O
RDWSD-55.0*	O
Plt	O
___	O
___	O
04:49AM	O
BLOOD	O
___	O
PTT-38.5*	O
___	O
___	O
04:49AM	O
BLOOD	O
Glucose-86	O
UreaN-7	O
Creat-0.4*	O
Na-135	O
K-4.3	O
Cl-96	O
HCO3-27	O
AnGap-12	O
___	O
04:49AM	O
BLOOD	O
ALT-21	O
AST-40	O
AlkPhos-145*	O
TotBili-0.7	O
___	O
04:49AM	O
BLOOD	O
Calcium-8.4	O
Phos-2.9	O
Mg-1.9	O
Micro:	O
___	O
6:49	O
am	O
BLOOD	O
CULTURE	O
Blood	O
Culture,	O
Routine	O
(Pending):	O
No	O
growth	O
to	O
date.	O
Imaging:	O
___	O
CXR:	O
Elevated	O
right	O
hemidiaphragm	O
may	O
be	O
secondary	O
to	O
right	O
lower	O
lobe	O
atelectasis.	O
Bibasilar	O
opacities	O
likely	O
reflect	O
atelectasis.	O
___	O
Arm	O
Xray:	O
10	O
intraoperative	O
images	O
were	O
acquired	O
without	O
a	O
radiologist	O
present.	O
Images	O
show	O
steps	O
during	O
an	O
intramedullary	O
nail	O
fixation	O
of	O
the	O
right	O
humerus.	O
For	O
details	O
of	O
the	O
Procedure,	O
please	O
refer	O
to	O
the	O
operative	O
note.	O
Total	O
fluoroscopic	O
time	O
most	O
205.3	O
seconds.	O
Xray	O
arm	O
___:	O
Again	O
seen	O
is	O
a	O
mottled	O
appearance	O
of	O
the	O
right	O
humerus	B-Proximal_humeral_fracture
with	O
an	O
oblique	O
fracture	B-Proximal_humeral_fracture
through	O
the	O
proximal	O
to	O
mid	O
right	O
humeral	B-Proximal_humeral_fracture
diaphysis.	B-Proximal_humeral_fracture
No	O
significant	O
displacement.	O
Distally,	O
no	O
additional	O
fractures	O
identified.	O
Brief	O
Hospital	O
Course:	O
___	O
PMH	O
of	O
castration-resistant	O
metastatic	O
prostate	O
cancer	O
(previously	O
on	O
docetaxel,	O
now	O
s/p	O
cycle	O
4	O
radium),	O
DVT	O
(on	O
Eliquis),	O
T2DM,	O
CAD,	O
presented	O
to	O
ED	O
with	O
right	O
arm	O
pain	O
found	O
to	O
have	O
pathologic	O
fracture	B-Proximal_humeral_fracture
of	O
right	O
humerus,	B-Proximal_humeral_fracture
now	O
s/p	O
ORIF	O
___,	O
discharged	O
to	O
rehab	O
with	O
plan	O
for	O
close	O
oncology/orthopedics	O
f/u	O
#Post	O
Operative	O
Fever	O
Occurred	O
post	O
operatively,	O
infectious	O
workup	O
identified	O
atelectasis	O
but	O
no	O
e/o	O
infection.	O
Abx	O
withheld	O
and	O
fever	O
self-resolved.	O
#	O
R	O
Proximal	B-Proximal_humeral_fracture
Humerus	B-Proximal_humeral_fracture
Fracture	B-Proximal_humeral_fracture
Atraumatic,	O
pathologic,	O
and	O
minimally	O
displaced.	O
Reassuringly	O
had	O
no	O
new	O
neurovascular	O
deficits.	O
Has	O
baseline	O
dysfunction	O
in	O
right	O
arm	O
___	O
prior	O
chemo	O
extravasation	O
event.	O
Ortho-onc	O
performed	O
ORIF	O
___	O
that	O
was	O
uneventful.	O
Rad	O
onc	O
evaluated	O
patient,	O
are	O
considering	O
radiation	O
for	O
symptom	O
control	O
but	O
can	O
not	O
be	O
done	O
within	O
2	O
weeks	O
of	O
ORIF,	O
so	O
pt	O
will	O
need	O
to	O
followup	O
with	O
them	O
as	O
an	O
outpatient	O
for	O
re-evaluation.	O
Ortho	O
appointment	O
scheduled	O
before	O
discharge,	O
patient	O
will	O
need	O
to	O
f/u	O
to	O
have	O
repeat	O
Xray's	O
and	O
staples	O
removed.	O
Length	O
of	O
stay	O
expected	O
to	O
be	O
less	O
than	O
30	O
days.	O
#	O
Castration-resistant	O
metastatic	O
prostate	O
cancer	O
Previously	O
on	O
docetaxel,	O
now	O
s/p	O
C4	O
Radium-223.	O
Unfortunately	O
he	O
has	O
no	O
other	O
options	O
for	O
his	O
prostate	O
ca.	O
He	O
might	O
be	O
eligible	O
for	O
two	O
more	O
doses	O
of	O
Radium-223	O
but	O
this	O
will	O
need	O
to	O
be	O
done	O
once	O
he	O
has	O
convalesced	O
and	O
returned	O
home.	O
The	O
benefits	O
at	O
this	O
stage	O
are	O
limited	O
and	O
palliative.	O
Per	O
Dr	O
___	O
expectancy	O
much	O
less	O
than	O
6	O
month,	O
but	O
as	O
per	O
my	O
discussions	O
with	O
patient	O
and	O
his	O
son/HCP	O
___,	O
patient	O
is	O
to	O
remain	O
FULL	O
CODE.	O
#	O
Chronic	O
Neoplasm	O
Related	O
Pain	O
Per	O
last	O
outpatient	O
pall	O
care	O
note,	O
patient	O
was	O
supposed	O
to	O
be	O
on	O
oxycontin	O
___	O
but	O
he	O
noted	O
that	O
he	O
was	O
only	O
taking	O
20	O
BID	O
at	O
home.Was	O
increased	O
to	O
30	O
QBID	O
to	O
account	O
for	O
increased	O
pain	O
from	O
humeral	B-Proximal_humeral_fracture
fracture,	B-Proximal_humeral_fracture
and	O
was	O
written	O
for	O
lidocaine	O
patches	O
+	O
gabapentin	O
+	O
capsacin	O
+	O
duloxetine	O
to	O
good	O
effect.	O
#Recent	O
dx	O
of	O
DVT	O
RLE	O
presentation	O
(edema/assymetric	O
enlargement)	O
unchanged	O
per	O
patient.	O
Resumed	O
apixaban	O
POD1	O
and	O
had	O
no	O
e/o	O
bleeding	O
#T2DM:	O
Previously	O
on	O
metformin.	O
AC1	O
5.5%	O
this	O
admit.	O
has	O
not	O
needed	O
insulin	O
while	O
here,	O
can	O
hold	O
off	O
on	O
___	O
at	O
rehab	O
#Anemia/Thrombocytopenia/Leukopenia:	O
Chronic,	O
likely	O
from	O
neoplastic	O
disease,	O
required	O
intermittent	O
blood	O
transfusion	O
during	O
stay.	O
Next	O
CBC	O
will	O
need	O
to	O
be	O
checked	O
on	O
___	O
with	O
transfusion	O
as	O
needed.	O
Transitional	O
issues:	O
1.	O
Ortho	O
appointment	O
scheduled	O
before	O
discharge,	O
patient	O
will	O
need	O
to	O
f/u	O
to	O
have	O
repeat	O
Xray's	O
and	O
staples	O
removed.	O
2.	O
Patient	O
will	O
need	O
to	O
be	O
referred	O
to	O
rad	O
onc	O
in	O
outpatient	O
setting	O
if	O
pain	O
persists	O
after	O
2	O
weeks	O
3.	O
Patient	O
will	O
need	O
to	O
schedule	O
outpatient	O
f/u	O
with	O
Dr	O
___	O
in	O
___	O
weeks	O
4.	O
Next	O
CBC	O
will	O
need	O
to	O
be	O
checked	O
on	O
___	O
with	O
transfusion	O
as	O
needed.	O
I	O
personally	O
spent	O
62	O
minutes	O
preparing	O
discharge	O
paperwork,	O
educating	O
patient,	O
answering	O
questions,	O
and	O
coordinating	O
care	O
with	O
outpatient	O
providers	O
___:	O
Opiates	O
were	O
needed	O
for	O
acute	O
pain	O
as	O
non-narcotic	O
medications	O
were	O
not	O
potent	O
enough	O
to	O
control	O
symptoms.	O
PMP	O
reviewed	O
prior	O
to	O
prescribing	O
This	O
patient	O
was	O
prescribed,	O
or	O
continued	O
on,	O
an	O
opioid	O
pain	O
medication	O
at	O
the	O
time	O
of	O
discharge	O
(please	O
see	O
the	O
attached	O
medication	O
list	O
for	O
details).	O
As	O
part	O
of	O
our	O
safe	O
opioid	O
prescribing	O
process,	O
all	O
patients	O
are	O
provided	O
with	O
an	O
opioid	O
risks	O
and	O
treatment	O
resource	O
education	O
sheet	O
and	O
encouraged	O
to	O
discuss	O
this	O
therapy	O
with	O
their	O
outpatient	O
providers	O
to	O
determine	O
if	O
opioid	O
pain	O
medication	O
is	O
still	O
indicated.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
2.	O
Acetaminophen	O
1000	O
mg	O
PO	O
TID	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
4.	O
Betamethasone	O
Dipro	O
0.05%	O
Oint	O
1	O
Appl	O
TP	O
BID	O
right	O
arm	O
hyperpigmentation	O
5.	O
Bisacodyl	O
___AILY:PRN	O
constipation	B-Constipation
6.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
7.	O
Gabapentin	O
400	O
mg	O
PO	O
TID	O
8.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
9.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
10.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
DAILY	O
11.	O
Senna	O
17.2	O
mg	O
PO	O
BID	O
12.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
13.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
DAILY	O
14.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
BID	O
15.	O
Ondansetron	O
ODT	O
4	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
16.	O
Lidocaine	O
5%	O
Patch	O
2	O
PTCH	O
TD	O
QAM	O
17.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
18.	O
OxyCODONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Moderate	O
19.	O
OxyCODONE	O
SR	O
(OxyCONTIN)	O
20	O
mg	O
PO	O
Q12H	O
Discharge	O
Medications:	O
1.	O
Capsaicin	O
0.025%	O
1	O
Appl	O
TP	O
TID	O
to	O
R	O
knee	O
and	O
arm	O
RX	O
*capsaicin	O
0.025	O
%	O
1	O
application	O
to	O
arm	O
and	O
knee	O
on	O
right	O
three	O
times	O
a	O
day	O
Refills:*0	O
2.	O
DULoxetine	O
___	O
30	O
mg	O
PO	O
DAILY	O
3.	O
OxyCODONE	O
SR	O
(OxyCONTIN)	O
30	O
mg	O
PO	O
Q12H	O
RX	O
*oxycodone	O
[OxyContin]	O
30	O
mg	O
1	O
tablet(s)	O
by	O
mouth	O
every	O
twelve	O
(12)	O
hours	O
Disp	O
#*10	O
Tablet	O
Refills:*0	O
4.	O
Polyethylene	O
Glycol	O
17	O
g	O
PO	O
BID	O
5.	O
Acetaminophen	O
1000	O
mg	O
PO	O
TID	O
6.	O
Apixaban	O
5	O
mg	O
PO	O
BID	O
7.	O
Ascorbic	O
Acid	O
___	O
mg	O
PO	O
DAILY	O
8.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
9.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
10.	O
Betamethasone	O
Dipro	O
0.05%	O
Oint	O
1	O
Appl	O
TP	O
BID	O
right	O
arm	O
hyperpigmentation	O
11.	O
Bisacodyl	O
___AILY:PRN	O
constipation	B-Constipation
12.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
BID	O
13.	O
Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O
14.	O
Gabapentin	O
400	O
mg	O
PO	O
TID	O
15.	O
Lidocaine	O
5%	O
Patch	O
2	O
PTCH	O
TD	O
QAM	O
16.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
17.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
18.	O
Ondansetron	O
ODT	O
4	O
mg	O
PO	O
Q8H:PRN	O
Nausea/Vomiting	O
-	O
First	O
Line	O
19.	O
OxyCODONE	O
(Immediate	O
Release)	O
___	O
mg	O
PO	O
Q4H:PRN	O
Pain	O
-	O
Moderate	O
RX	O
*oxycodone	O
5	O
mg	O
___	O
tablet	O
by	O
mouth	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
20.	O
Senna	O
17.2	O
mg	O
PO	O
BID	O
21.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
#Fever	O
#	O
R	O
Proximal	B-Proximal_humeral_fracture
Humerus	B-Proximal_humeral_fracture
Fracture	B-Proximal_humeral_fracture
#	O
Castration-resistant	O
metastatic	O
prostate	O
cancer	O
#	O
Acute	O
on	O
Chronic	O
Neoplasm	O
Related	O
Pain	O
#Recent	O
dx	O
of	O
DVT	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Independently_mobile
-	B-Independently_mobile
Independent.	B-Independently_mobile
Discharge	O
Instructions:	O
Mr	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
while	O
you	O
were	O
hospitalized	O
at	O
___.	O
As	O
you	O
know,	O
you	O
were	O
admitted	O
for	O
a	O
right	O
arm	B-Proximal_humeral_fracture
fracture	B-Proximal_humeral_fracture
due	O
to	O
your	O
cancer,	O
and	O
had	O
an	O
operation	O
to	O
stabilize	O
it.	O
You	O
will	O
need	O
to	O
attend	O
your	O
outpatient	O
orthopedics	O
appt	O
in	O
1	O
week	O
to	O
have	O
staples	O
removed	O
and	O
arm	O
re-evaluated.	O
Your	O
pain	O
medications	O
were	O
increased	O
as	O
a	O
result	O
of	O
your	O
fracture	O
Dr	O
___	O
was	O
aware	O
of	O
your	O
hospitalization.	O
Please	O
call	O
him	O
to	O
schedule	O
a	O
followup	O
appointment	O
in	O
___	O
weeks.	O
Followup	O
Instructions:	O
___	O

